Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gallant J, Lazzarin A, Mills A, Orkin C, et al. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial. Lancet 2017 Aug 31. pii: S0140-6736(17)32299.
PMID: 28867497

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016